Testing BRCA 1/2 Mutation Using Next Generation Sequencing

计划入组 12 人 · 首次发布于 2014 年 5 月 30 日

Counseling Interventions for BRCA 1/2 Cancer Susceptibility Testing

计划入组 150 人 · 首次发布于 2005 年 9 月 14 日

Single Arm Study of BSI-201 in Patients With BRCA-1 or BRCA-2 Associated Advanced Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

计划入组 12 人 · 首次发布于 2008 年 5 月 13 日

Artesunate(Artesunate Amivas)

C₁₉H₂₈O₈ · Rx

MEREO BIOPHARMA 2 LIMITED

United Kingdom

UpJohn US 2 LLC

United States

RIVER 2 RENAL CORP.

United States

From Fashion Week to Cancer-Free: A Model's Journey with Triple-Negative Breast Cancer Highlights Barriers to Timely Care

Accent Therapeutics to Showcase Novel Cancer Therapeutics ATX-559 and ATX-295 at AACR 2025

Neoadjuvant Therapies Show Promise in High-Risk Localized Prostate Cancer